High doses of IL-2, either alone or combined with other cancer vaccines, can mediate anti-tumor immunity and was studied extensively as cancer therapeutic cytokines in clinical trials; however, its toxicity limited its therapeutic benefits47. The gene discussed is IL2; the disease is neoplasm.